adenoid hypertrophy
Conditions
Interventions
the control group:intranasal mometasone furoate
the treatment group:Electroacupuncture Incorporating Warm Needling
Sponsors
Foshan Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
3 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the diagnostic criteria related to adenoid hypertrophy; (2) Individuals aged between 3 and 12 years old for enrollment; (3) Obtain the informed consent of the guardian and sign the informed consent form (for children aged eight and above who have the ability to decide whether to participate in clinical trials obtain written informed consent from themselves and their guardians) and voluntarily participate in clinical observation.
Exclusion criteria
Exclusion criteria: (1) Age below 3 years old and above 12 years old; (2) Those who received medication treatment 4 weeks before treatment; (3) Sleep snoring and mouth breathing caused by non adenoid hypertrophy such as obesity deviated nasal septum sinusitis and nasal injury; (4) Allergies to mometasone furoate nasal spray or other serious adverse reactions; (5) Individuals with infectious diseases or mental illnesses;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptom scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| adenoid-nasopharyngeal ratio;18-item(OSA-18) health-related quality-of-life survey; | — |
Countries
CHINA
Contacts
Public ContactDeng Cong
Guangzhou University of Traditional Chinese Medicine Eighth Clinical Medical College; Foshan Hospital of Traditional Chinese Medicine; Foshan Gaoming District Hospital of Traditional Chinese Medicine
Outcome results
None listed